Effects of Unilateral High Frequency Stimulation of the Subthalamic Nucleus on Risk-avoidant Behavior in a Partial 6-hydroxydopamine Model of Parkinson's Disease

J Integr Neurosci. 2024 Apr 19;23(4):84. doi: 10.31083/j.jin2304084.

Abstract

Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well-established treatment for the motor symptoms of Parkinson's disease (PD). While PD is primarily characterized by motor symptoms such as tremor, rigidity, and bradykinesia, it also involves a range of non-motor symptoms, and anxiety is one of the most common. The relationship between PD and anxiety is complex and can be a result of both pathological neural changes and the psychological and emotional impacts of living with a chronic progressive condition. Managing anxiety in PD is critical for improving the patients' quality of life. However, patients undergoing STN DBS can occasionally experience increased anxiety.

Methods: This study investigates changes in risk-avoidant behavior following STN DBS in a pre-motor animal model of PD under chronic and acute unilateral high frequency stimulation.

Results: No significant changes in risk-avoidant behaviors were observed in rats who underwent STN DBS compared with sham stimulation controls. Chronic stimulation prevented sensitization in the elevated zero maze.

Conclusions: These results suggest that unilateral stimulation of the STN may have minimal effects on risk-avoidant behaviors in PD. However, additional research is required to fully understand the mechanisms responsible for changes in anxiety during STN DBS for PD.

Keywords: 6-hydroxydopamine; Parkinson's disease; deep brain stimulation; risk-avoidance; subthalamic nucleus.

MeSH terms

  • Animals
  • Anxiety / etiology
  • Anxiety / physiopathology
  • Avoidance Learning / physiology
  • Behavior, Animal / physiology
  • Deep Brain Stimulation*
  • Disease Models, Animal*
  • Male
  • Oxidopamine* / pharmacology
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy
  • Parkinsonian Disorders / physiopathology
  • Parkinsonian Disorders / therapy
  • Rats
  • Rats, Sprague-Dawley
  • Subthalamic Nucleus*

Substances

  • Oxidopamine